Literature DB >> 11388093

Dermatologic manifestations of relapsing polychondritis. A study of 200 cases at a single center.

C Francès1, R el Rassi, J L Laporte, M Rybojad, T Papo, J C Piette.   

Abstract

Dermatologic manifestations of relapsing polychondritis (RP) have been relatively poorly studied compared to other manifestations. In this study we describe dermatologic manifestations in a large series of patients with RP and the corresponding pathologic findings. In this retrospective, single-center review of 200 patients diagnosed with RP according to Michet's criteria, we analyzed separately those suffering from associated diseases with potential dermatologic involvement or chronic dermatitis. Skin or mucosal biopsies taken from 59 patients were examined without knowledge of the clinical data. Among the 200 patients with RP, 73 had chronic dermatitis or associated diseases with potential dermatologic involvement, especially hematologic disorders (n = 24) and connective tissue diseases (n = 22). Among the other 127 patients, 45 (35.4%) had dermatologic manifestations: aphthosis (n = 21; oral in 14 and complex in 7), nodules on the limbs (n = 19), purpura (n = 13), papules (n = 10), sterile pustules (n = 9), superficial phlebitis (n = 8), livedo reticularis (n = 7), ulcerations on the limbs (n = 6), and distal necrosis (n = 4). Dermatologic manifestations were the presenting feature of RP in 15 cases (12%), and appeared concomitantly (n = 23) or not (n = 22) with attacks of chondritis. Histologic findings included vasculitis (n = 19, leukocytoclastic in 17 and lymphocytic in 2), neutrophil infiltrates (n = 6), thrombosis of skin vessels (n = 4), septal panniculitis (n = 3), and minor changes (n = 2). Patients with and without dermatologic manifestations did not differ with regard to male/female ratio; age at RP onset; frequency of auricular, nasal, or tracheobronchial chondritis; or frequency of rheumatologic, ocular, audiovestibular, renal, arterial, or venous involvement. The frequency of dermatologic manifestations (91% versus 35.4%; p < 0.0001), sex ratio (18 male/4 female versus 44 male/83 female, p < 0.0001), and age at first chondritis (63.3 +/- 14 yr versus 41.4 +/- 17 yr; p < 0.0002) were significantly higher in the 22 patients with myelodysplastic syndrome than in the 127 patients without any associated disease. In conclusion, although dermatologic manifestations occur frequently in patients with RP, especially in association with myelodysplasia, they are nonspecific and sometimes resemble those observed in Behçet disease or inflammatory bowel diseases. Their presence in the elderly warrants repeated blood cell counts to detect a smouldering myelodysplasia.

Entities:  

Mesh:

Year:  2001        PMID: 11388093     DOI: 10.1097/00005792-200105000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  28 in total

1.  Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis.

Authors:  Sarah Keidel; Aubretia McColl; Sally Edmonds
Journal:  BMJ Case Rep       Date:  2011-12-21

Review 2.  Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives.

Authors:  Antonio Vitale; Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Francesco Molinaro; Mario Messina; Florenzo Iannone; Luca Cantarini
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

3.  Cutaneous manifestations of patients with relapsing polychondritis: an association with extracutaneous complications.

Authors:  Jun Shimizu; Hiroshi Oka; Yoshihisa Yamano; Kazuo Yudoh; Noboru Suzuki
Journal:  Clin Rheumatol       Date:  2016-01-16       Impact factor: 2.980

Review 4.  Relapsing polychondritis: a review.

Authors:  Aman Sharma; Karthik Gnanapandithan; Kusum Sharma; Susmita Sharma
Journal:  Clin Rheumatol       Date:  2013-07-26       Impact factor: 2.980

5.  [Acute mesenteric ischemia in a patient with relapsing polychondritis].

Authors:  O Schultz; R Ruckert; G Burmester; F Buttgereit
Journal:  Z Rheumatol       Date:  2006-02       Impact factor: 1.372

6.  Patient-perceived Burden of Disease in Pediatric Relapsing Polychondritis.

Authors:  Casey A Rimland; Marcela A Ferrada; Ninet Sinaii; Keith A Sikora; Robert A Colbert; Peter C Grayson; James D Katz
Journal:  J Rheumatol       Date:  2019-05-01       Impact factor: 4.666

Review 7.  Relapsing polychondritis: a chameleon among orphan diseases.

Authors:  Sabine Schumacher; Herwig Pieringer
Journal:  Wien Med Wochenschr       Date:  2017-03-31

Review 8.  Relapsing polychondritis.

Authors:  Hakan Emmungil; Sibel Zehra Aydın
Journal:  Eur J Rheumatol       Date:  2015-12-01

9.  Observational study and brief analysis of diagnostic criteria in relapsing polychondritis.

Authors:  Thomas Rose; Udo Schneider; Martina Bertolo; Jens Klotsche; Vincent Casteleyn; Robert Biesen; Gerd R Burmester; Falk Hiepe
Journal:  Rheumatol Int       Date:  2018-08-06       Impact factor: 2.631

10.  Coexisting relapsing polychondritis and sarcoidosis: an unusual association.

Authors:  Florian Pasquet; Vincent Cottin; Nadia Sivova; Julie Le Scanff; Christiane Broussolle; Pascal Sève
Journal:  Rheumatol Int       Date:  2009-08-28       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.